Ultimate magazine theme for WordPress.

Emerald Health Therapeutics positioning itself for 'Cannabis 2.0'


Emerald Health Therapeutics Inc (TSXV:EMH) (OTCQX:EMHTF) Vice President Bernie Hertel tells Proactive Investors the Vancouver-based cannabis company is positioning itself for ‘Cannabis 2.0’, the 17 October 2019 date where regulations change in Canada, and edibles, infused beverages, topicals, concentrates, and vapes will be officially available for sale in mid-December.

Hertel says while the company hasn’t disclosed what their product line will look like, the company is ‘working behind the scenes’ to deliver new products. The company recently received its processing license from Health Canada for its greenhouse facility at its 50%-owned joint venture, Pure Sunfarms.


Leave A Reply

Your email address will not be published.